Coca-Cola Europacific Partners plc (the "Company")
Transactions in Own Shares
The Company confirms that on:
(a) 02 May 2025 it purchased a total of: (i) 29,925 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 30,256 ordinary shares on the London Trading Venues[2]; and
(b) 05 May 2025 it purchased a total of: (i) 30,130 ordinary shares of EUR 0.01 on the US Trading Venues and (ii) 0 ordinary shares3 on the London Trading Venues,
in each case, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.
The repurchased ordinary shares will be cancelled.
02 May 2025
| US Trading Venues | London Stock Exchange | CBOE Europe Limited (CXE) | CBOE Europe Limited (BXE) | Aquis | |
| Date of purchase | 02 May 2025 | 02 May 2025 | 02 May 2025 | 02 May 2025 | 02 May 2025 |
| Aggregate number of ordinary shares purchased | 29,925 | 18,153 | 3,026 | 9,077 | 0 |
| Highest price paid (per ordinary share) | USD 90.6000 | GBP 68.1000 | GBP 68.1000 | GBP 68.1000 | GBP 0 |
| Lowest price paid (per ordinary share) | USD 89.6500 | GBP 67.2000 | GBP 67.2000 | GBP 67.4000 | GBP 0 |
| Volume weighted average price paid (per ordinary share) | USD 90.1029 | GBP 67.8958 | GBP 67.8740 | GBP 67.8812 | GBP 0 |
05 May 2025
| US Trading Venues | London Stock Exchange | CBOE Europe Limited (CXE) | CBOE Europe Limited (BXE) | Aquis | |
| Date of purchase | 05 May 2025 | 05 May 2025 | 05 May 2025 | 05 May 2025 | 05 May 2025 |
| Aggregate number of ordinary shares purchased | 30,130 | 0 | 0 | 0 | 0 |
| Highest price paid (per ordinary share) | USD 90.0000 | GBP 0 | GBP 0 | GBP 0 | GBP 0 |
| Lowest price paid (per ordinary share) | USD 88.3700 | GBP 0 | GBP 0 | GBP 0 | GBP 0 |
| Volume weighted average price paid (per ordinary share) | USD 89.4889 | GBP 0 | GBP 0 | GBP 0 | GBP 0 |
The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).
This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, are set out in the Schedule to this announcement available through the link below:
http://www.rns-pdf.londonstockexchange.com/rns/4361H_1-2025-5-5.pdf
CONTACTS
| Company Secretariat Clare Wardle clare.wardle@ccep.com | Investor Relations Sarah Willett sarah.willett@ccep.com | Media Relations Shanna Wendt mediaenquiries@ccep.com |
ABOUT CCEP
Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.
We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.
The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the Nasdaq 100 and FTSE 100 indices, trading under the symbol CCEP.
For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn
[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.
[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.
3 No ordinary shares were purchased on the London Trading Venues on 05 May 2025 due to market closure for the UK's Early May Bank Holiday.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com